Clinical trialNCT06069570RecruitingPhase 1Interventional

Safety Study for a Gamma Delta T Cell Product Used With Low Dose Radiotherapy in Patients With Locally Advanced or Metastatic NSCLC or Solid Tumors With Bone Metastases

SponsorKiromic BioPharma Inc.Enrollment48Bone Metastases From Solid TumorsCarcinoma, Non-Small-Cell Lung Cancer

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Jason J Luke, MD, FACP
University of Pittsburgh
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

the University of Arizona Cancer Center
Tucson, Arizona, United States
Ricklie Julian, MD
Not, yet, recruiting
Beverly Hills Cancer Center
Beverly Hills, California, United States
Afshin Gabayan, MD
Recruiting
Upmc Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
Jason Luke, MD
Recruiting
Texas Oncology - Tyler
Tyler, Texas, United States
Donald Richards, MD, PhD
Recruiting
Virginia Oncology Associates
Norfolk, Virginia, United States
Gary Simmons, DO, MSHA
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 7 Nov 2023
Primary completion: 31 Oct 2025
Completion: 31 Oct 2026
Last update posted: 5 Mar 2025
Registered enrollment: 48
Registry id: NCT06069570

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.